Onconova Therapeutics Inc. to Present Clinical Trials Update for Estybon(R) (ON 01910.Na) at the American Society of Hematology Annual Meeting

NEWTOWN, Pa. & PRINCETON, N.J.--(BUSINESS WIRE)--Onconova Therapeutics announces its late-stage anticancer agent, Estybon® (ON 01910.Na), will be featured in three presentations at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, FL, December 4-7, 2010.